BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30080928)

  • 1. External electrical cardioversion in patients with cardiac implantable electronic devices: Is it safe and is immediate device interrogation necessary?
    Pluymaekers NAHA; Dudink EAMP; Boersma L; Erküner Ö; Gelissen M; van Dijk V; Wijffels M; Dinh T; Vernooy K; Crijns HJ; Balt J; Luermans JGLM
    Pacing Clin Electrophysiol; 2018 Oct; 41(10):1336-1340. PubMed ID: 30080928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External cardioversion of atrial fibrillation and flutter in patients with cardiac implantable electrical devices.
    Elgaard AF; Dinesen PT; Riahi S; Hansen J; Lundbye-Christensen S; Thøgersen AM; Larsen JM
    Pacing Clin Electrophysiol; 2023 Feb; 46(2):108-113. PubMed ID: 36333921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices.
    Do DH; Eyvazian V; Bayoneta AJ; Hu P; Finn JP; Bradfield JS; Shivkumar K; Boyle NG
    Heart Rhythm; 2018 Feb; 15(2):218-225. PubMed ID: 29017930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical cardioversion of patients with implanted pacemaker or cardioverter-defibrillator: results of a survey of german centers and systematic review of the literature.
    Lüker J; Sultan A; Plenge T; van den Bruck J; Heeger CH; Meyer S; Mischke K; Tilz RR; Vollmann D; Nölker G; Schäffer B; Willems S; Steven D
    Clin Res Cardiol; 2018 Mar; 107(3):249-258. PubMed ID: 29151182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term risk of cardiovascular implantable electronic device reinterventions following external cardioversion of atrial fibrillation and flutter: A nationwide cohort study.
    Elgaard AF; Dinesen PT; Riahi S; Hansen J; Lundbye-Christensen S; Johansen JB; Nielsen JC; Lip GYH; Larsen JM
    Heart Rhythm; 2023 Sep; 20(9):1227-1235. PubMed ID: 36965653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoracic versus nonthoracic MR imaging for patients with an MR nonconditional cardiac implantable electronic device.
    Nyotowidjojo IS; Skinner K; Shah AS; Bisla J; Singh S; Khoubyari R; Ott P; Kalb B; Indik JH
    Pacing Clin Electrophysiol; 2018 Jun; 41(6):589-596. PubMed ID: 29603272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of external electrical cardioversion in patients with left ventricular leads.
    Lüker J; von Bodman G; Sultan A; Brömsen J; Akbulak RÖ; Schäffer B; Schreiber D; Hoffmann BA; Block M; Willems S; Steven D
    Clin Res Cardiol; 2015 May; 104(5):439-45. PubMed ID: 25466548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmortem Interrogation of Cardiac Implantable Electronic Devices: A 15-Year Experience.
    Paratz ED; Block TJ; Stub DA; La Gerche A; Kistler PM; Kalman JM; Strathmore N; Mond H; Woodford NWF; Burke M; Voskoboinik A
    JACC Clin Electrophysiol; 2022 Mar; 8(3):356-366. PubMed ID: 35331431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and compatibility of smart device heart rhythm monitoring in patients with cardiovascular implantable electronic devices.
    Abudan AA; Isath A; Ryan JD; Henrich MJ; Dugan JL; Attia ZI; Ladewig DJ; Dillon JJ; Friedman PA
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1602-1609. PubMed ID: 31190453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal Versus External Electrical Cardioversion of Atrial Arrhythmia in Patients With Implantable Cardioverter-Defibrillator: A Randomized Clinical Trial.
    Lüker J; Kuhr K; Sultan A; Nölker G; Omran H; Willems S; Andrié R; Schrickel JW; Winter S; Vollmann D; Tilz RR; Jobs A; Heeger CH; Metzner A; Meyer S; Mischke K; Napp A; Fahrig A; Steinhauser S; Brachmann J; Baldus S; Mahajan R; Sanders P; Steven D
    Circulation; 2019 Sep; 140(13):1061-1069. PubMed ID: 31466479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy-Induced Malfunction in Contemporary Cardiovascular Implantable Electronic Devices: Clinical Incidence and Predictors.
    Grant JD; Jensen GL; Tang C; Pollard JM; Kry SF; Krishnan S; Dougherty AH; Gomez DR; Rozner MA
    JAMA Oncol; 2015 Aug; 1(5):624-32. PubMed ID: 26181143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application.
    Manegold JC; Israel CW; Ehrlich JR; Duray G; Pajitnev D; Wegener FT; Hohnloser SH
    Eur Heart J; 2007 Jul; 28(14):1731-8. PubMed ID: 17569681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Quality of 1.5-T MRI in Patients With Conventional and MRI-Conditional Cardiac Implantable Electronic Devices After Implementation of a Standardized Protocol.
    Camacho JC; Moreno CC; Shah AD; Mittal PK; Mengistu A; Lloyd MS; El-Chami MF; Lerakis S; Saindane AM
    AJR Am J Roentgenol; 2016 Sep; 207(3):599-604. PubMed ID: 27304515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted longevity of contemporary cardiac implantable electronic devices: A call for industry-wide "standardized" reporting.
    Munawar DA; Mahajan R; Linz D; Wong GR; Khokhar KB; Thiyagarajah A; Kadhim K; Emami M; Mishima R; Elliott AD; Middeldorp ME; Roberts-Thompson KC; Young GD; Sanders P; Lau DH
    Heart Rhythm; 2018 Dec; 15(12):1756-1763. PubMed ID: 30063990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging in non-conditional pacemakers and implantable cardioverter-defibrillators: a systematic review and meta-analysis.
    Munawar DA; Chan JEZ; Emami M; Kadhim K; Khokhar K; O'Shea C; Iwai S; Pitman B; Linz D; Munawar M; Roberts-Thomson K; Young GD; Mahajan R; Sanders P; Lau DH
    Europace; 2020 Feb; 22(2):288-298. PubMed ID: 31995177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmortem interrogation of cardiac implantable electrical devices may clarify time and cause of death.
    Riesinger L; Fichtner S; Schuhmann CG; Estner HL; Czermak T; Graw M; Fischer F; Lackermair K
    Int J Legal Med; 2019 May; 133(3):883-888. PubMed ID: 30238160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring.
    Nishii N; Miyoshi A; Kubo M; Miyamoto M; Morimoto Y; Kawada S; Nakagawa K; Watanabe A; Nakamura K; Morita H; Ito H
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):463-470. PubMed ID: 29194831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy-Induced Cardiac Implantable Electronic Device Dysfunction in Patients With Cancer.
    Bagur R; Chamula M; Brouillard É; Lavoie C; Nombela-Franco L; Julien AS; Archambault L; Varfalvy N; Gaudreault V; Joncas SX; Israeli Z; Parviz Y; Mamas MA; Lavi S
    Am J Cardiol; 2017 Jan; 119(2):284-289. PubMed ID: 27823600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of radiation therapy on permanent pacemaker and implantable cardioverter-defibrillator function.
    Makkar A; Prisciandaro J; Agarwal S; Lusk M; Horwood L; Moran J; Fox C; Hayman JA; Ghanbari H; Roberts B; Belardi D; Latchamsetty R; Crawford T; Good E; Jongnarangsin K; Bogun F; Chugh A; Oral H; Morady F; Pelosi F
    Heart Rhythm; 2012 Dec; 9(12):1964-8. PubMed ID: 23102626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.